AOBiome logo

AOBiome

AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that developed strains of Ammonia Oxidizing Bacteria (AOB) to administer live in treatments that address inflammatory conditions.

5

Funding Rounds

$68.7m

Money raised

Overview

AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that developed strains of Ammonia Oxidizing Bacteria (AOB) to administer live in treatments that address inflammatory conditions.

Funding series

Funding Series Analysis

The company AOBiome has raised a total of $30m in funding over 5 rounds.

Key Insights:

  • AOBiome Funding Round 2017: $30m
  • AOBiome Series B Funding Round December 2014: $7.5m
  • AOBiome Seed Funding Round March 2013: $630k
  • AOBiome Series C Funding Round January 2017: $30m
  • AOBiome Venture Funding Round August 2014: $576.5k
AOBiome logo
AOBiome Funding Round 2017 $30m
AOBiome logo
AOBiome Seed Funding Round March 2013 $630k
AOBiome logo
AOBiome Venture Funding Round August 2014 $576.5k
AOBiome logo
AOBiome Series B Funding Round December 2014 $7.5m
AOBiome logo
AOBiome Series C Funding Round January 2017 $30m

Industries

AOBiome is active in the following industries:
  • Consumer
  • Microbiome
  • Therapeutics
  • Therapy
  • Dermatology
  • Biomedical engineering
  • Skin care
  • Technology
  • Synthetic biology
  • Biology
  • Biotechnology
  • Internal medicine
  • Healthcare
  • Medicine
  • Microbiology
  • Engineering